Elan Corp, plc (ADR) (ELN)
$6.58
0.38 (+6.13%)
| CAPS Rating |
|
|---|---|
| Open | $6.11 |
| Previous Close | $6.20 |
| Daily Range | $6.10 - $6.64 |
| 52-Week Range | $4.61 - $9.13 |
| Market Cap | $3.1B |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 11,213,600 |
| Average Daily Volume | 5,822,000 |
ELN
VS S&P 500 (SPY)
How do you think ELN will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
ELN Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
ELN News and Commentary
- CNBC on Elan Corp. PLC – Ockham-RazorWire
- CNBC on Elan Corp. PLC – Ockham-RazorWire
- Nice Quarter, Teva. What Will You Buy Next? – The Motley Fool
- 3 Stocks in a Tailspin – The Motley Fool
- 5-Star Stocks Poised to Pop: MEMC – The Motley Fool
- For Tysabri, 23 Is 10 Too Many – The Motley Fool
- 5 Superball Stocks – The Motley Fool
- 4-Star Stocks Poised to Pop: Elan – The Motley Fool
- Elan's Headed in the Right Direction – The Motley Fool
- All Tysabri, All the Time – The Motley Fool
- This Just In: Upgrades and Downgrades – The Motley Fool
- Baxter Beats Again -- the Streak Is Alive! – The Motley Fool
- Little Discord on Acorda Drug – The Motley Fool
- J&J Needs to Get Drugged Up – The Motley Fool
- 5 Stocks Approaching Greatness – The Motley Fool
- Acorda's Upcoming Excitement – The Motley Fool
- Why I'm Invested in Tysabri and Elan – The Motley Fool
- Less Is More for Novartis – The Motley Fool
- More Questions Than Answers From Elan – The Motley Fool
- New Issue-Elan sells $625 mln in 7-yr senior notes – Reuters
RSS Headlines
Fool UK
